| pubmed-article:16322303 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16322303 | lifeskim:mentions | umls-concept:C0021756 | lld:lifeskim |
| pubmed-article:16322303 | lifeskim:mentions | umls-concept:C0023434 | lld:lifeskim |
| pubmed-article:16322303 | lifeskim:mentions | umls-concept:C1334170 | lld:lifeskim |
| pubmed-article:16322303 | lifeskim:mentions | umls-concept:C0010583 | lld:lifeskim |
| pubmed-article:16322303 | lifeskim:mentions | umls-concept:C0059985 | lld:lifeskim |
| pubmed-article:16322303 | lifeskim:mentions | umls-concept:C0920321 | lld:lifeskim |
| pubmed-article:16322303 | pubmed:issue | 23 | lld:pubmed |
| pubmed-article:16322303 | pubmed:dateCreated | 2005-12-2 | lld:pubmed |
| pubmed-article:16322303 | pubmed:abstractText | Fludarabine and cyclophosphamide is an effective combination but increases the risk of opportunistic infections due to depressed lymphocyte counts. In an attempt to preserve CD4 counts, we conducted a phase I, double-blind, placebo-controlled trial of recombinant interleukin-2 (IL-2) added to fludarabine and cyclophosphamide in patients with treatment-naive indolent lymphomas or chronic lymphocytic leukemia. | lld:pubmed |
| pubmed-article:16322303 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16322303 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16322303 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16322303 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16322303 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16322303 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16322303 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16322303 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16322303 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16322303 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16322303 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:16322303 | pubmed:issn | 1078-0432 | lld:pubmed |
| pubmed-article:16322303 | pubmed:author | pubmed-author:GoodmanSteven... | lld:pubmed |
| pubmed-article:16322303 | pubmed:author | pubmed-author:ByrdJohn CJC | lld:pubmed |
| pubmed-article:16322303 | pubmed:author | pubmed-author:FlinnIan WIW | lld:pubmed |
| pubmed-article:16322303 | pubmed:author | pubmed-author:KasamonYvette... | lld:pubmed |
| pubmed-article:16322303 | pubmed:author | pubmed-author:GreverMichael... | lld:pubmed |
| pubmed-article:16322303 | pubmed:author | pubmed-author:LucasMargaret... | lld:pubmed |
| pubmed-article:16322303 | pubmed:author | pubmed-author:Garrett-Mayer... | lld:pubmed |
| pubmed-article:16322303 | pubmed:author | pubmed-author:DiehlLouis... | lld:pubmed |
| pubmed-article:16322303 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16322303 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:16322303 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:16322303 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16322303 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16322303 | pubmed:pagination | 8413-7 | lld:pubmed |
| pubmed-article:16322303 | pubmed:dateRevised | 2009-12-30 | lld:pubmed |
| pubmed-article:16322303 | pubmed:meshHeading | pubmed-meshheading:16322303... | lld:pubmed |
| pubmed-article:16322303 | pubmed:meshHeading | pubmed-meshheading:16322303... | lld:pubmed |
| pubmed-article:16322303 | pubmed:meshHeading | pubmed-meshheading:16322303... | lld:pubmed |
| pubmed-article:16322303 | pubmed:meshHeading | pubmed-meshheading:16322303... | lld:pubmed |
| pubmed-article:16322303 | pubmed:meshHeading | pubmed-meshheading:16322303... | lld:pubmed |
| pubmed-article:16322303 | pubmed:meshHeading | pubmed-meshheading:16322303... | lld:pubmed |
| pubmed-article:16322303 | pubmed:meshHeading | pubmed-meshheading:16322303... | lld:pubmed |
| pubmed-article:16322303 | pubmed:meshHeading | pubmed-meshheading:16322303... | lld:pubmed |
| pubmed-article:16322303 | pubmed:meshHeading | pubmed-meshheading:16322303... | lld:pubmed |
| pubmed-article:16322303 | pubmed:meshHeading | pubmed-meshheading:16322303... | lld:pubmed |
| pubmed-article:16322303 | pubmed:meshHeading | pubmed-meshheading:16322303... | lld:pubmed |
| pubmed-article:16322303 | pubmed:meshHeading | pubmed-meshheading:16322303... | lld:pubmed |
| pubmed-article:16322303 | pubmed:meshHeading | pubmed-meshheading:16322303... | lld:pubmed |
| pubmed-article:16322303 | pubmed:meshHeading | pubmed-meshheading:16322303... | lld:pubmed |
| pubmed-article:16322303 | pubmed:meshHeading | pubmed-meshheading:16322303... | lld:pubmed |
| pubmed-article:16322303 | pubmed:meshHeading | pubmed-meshheading:16322303... | lld:pubmed |
| pubmed-article:16322303 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16322303 | pubmed:articleTitle | Phase I study of low-dose interleukin-2, fludarabine, and cyclophosphamide for previously untreated indolent lymphoma and chronic lymphocytic leukemia. | lld:pubmed |
| pubmed-article:16322303 | pubmed:affiliation | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland 21231, USA. ykasamo1@jhmi.edu | lld:pubmed |
| pubmed-article:16322303 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16322303 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:16322303 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:16322303 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |
| pubmed-article:16322303 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16322303 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16322303 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16322303 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16322303 | lld:pubmed |
